scispace - formally typeset
Search or ask a question

Showing papers by "Lee A. Green published in 2017"


Journal ArticleDOI
TL;DR: The 2017 HF guidelines provide updated guidance on the diagnosis and management that should aid in day-to-day decisions for caring for patients with HF, with attention to strategies and treatments to prevent HF, to the organization of HF care, comorbidity management, as well as practical issues around the timing of referral and follow-up care.

465 citations



Journal ArticleDOI
TL;DR: To unleash the potential of electronic clinical alerts, electronic health record and health care institutions need to address some key barriers, such as addressing Physicians’ mental models by focusing on physicians’ expertise rather than knowledge to improve their comfort when caring for patients with the conditions being prompted.

22 citations


Journal ArticleDOI
TL;DR: The electronic clinical prompt significantly increased audiology referrals for at-risk patients for HL in two family medicine clinics and the diagnosis of HL on problem lists increased.

16 citations


Journal ArticleDOI
TL;DR: Clinically important improvements were demonstrated in the intervention versus comparison practices, with diabetic patients improving A1c control and obese patients experiencing weight loss.
Abstract: Background: To address the increasing burden of chronic disease, many primary care practices are turning to care management and the hiring of care managers to help patients coordinate their care an...

13 citations


Journal ArticleDOI
TL;DR: For a typical patient in my practice with Stage I hypertension and 1 or more other cardiovascular risk factors, the number needed to treat for 5 years to prevent a death, acute coronary event, stroke, heart failure, or renal failure is only 11, and patients at higher risk (especially those
Abstract: For a typical patient in my practice with Stage I hypertension and 1 or more other cardiovascular risk factors, the number needed to treat (NNT) for 5 years to prevent a death, acute coronary event, stroke, heart failure, or renal failure is only 11, and patients at higher risk (especially those

6 citations


01 Jan 2017
TL;DR: Although the medical community has embraced the use of statins for primary prevention in the very elderly, caution should be exercised given the potential dangers of expanding marginally effective treatments to untested populations.
Abstract: Discussion | One-third of community-dwelling very elderly individuals without vascular disease reported a statin prescription despite a lack of randomized clinical trials to support their use.1,2 Despite a lack of clear recommendation for statin use in the primary prevention of the very elderly within the Adult Treatment Panel III guideline,6 there was a large increase in use that coincided with its release. The primary limitation of our study is the change in the classification of vascular disease, which likely increased the sensitivity and decreased the specificity of vascular disease. Hence, the classification of primary prevention likely became more conservative. Although the medical community has embraced the use of statins for primary prevention in the very elderly, caution should be exercised given the potential dangers of expanding marginally effective treatments to untested populations.

2 citations